How to appeal a Cigna pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Cited policy: Cigna Coverage Policy on IVIG + Kawasaki Disease (mirrors AAP/AHA 2017)

AAP/AHA Scientific Statement on Kawasaki (McCrindle Circulation 2017): IVIG 2g/kg + high-dose ASA within 10 days of fever onset for classic or incomplete Kawasaki meeting criteria; echo with coronary z-scores at baseline + 2 wk + 6-8 wk; peds cards involvement.

How Cigna denies pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology — and how to counter it

Where Cigna pushes back: 1) Incomplete Kawasaki criteria 'not yet met'; 2) IVIG dose 'excessive'; 3) Repeat IVIG / infliximab for non-responder questioned.

Counter-arguments that hold up: Cite AAP/AHA Kawasaki Scientific Statement (McCrindle Circulation 2017) — incomplete Kawasaki algorithm with lab supplementary criteria (CRP, ESR, anemia, plt, ALT, albumin, urine WBC). IVIG 2g/kg single infusion is the AAP/AHA standard. For IVIG-resistant: repeat IVIG OR infliximab 5-10 mg/kg per AAP/AHA. Document fever days + clinical criteria + lab supplementary + echo coronary z-scores.

What Cigna typically denies for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Peds congenital heart surgery
• Kawasaki workup + IVIG
• Pediatric ECMO
• Peds EoE workup + therapy
• Peds IBD biologic
• Peds asthma biologic / admission

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.